miR-145 transgenic mice develop cardiopulmonary complications leading to postnatal death

Shelby Thomas1, Sathiyanarayanan Manivannan1, Dwitiya Sawant1

  • 1Center for Cardiovascular Research and The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.

Physiological Reports
|September 15, 2021
PubMed
Abstract

Insights

Elevated microRNA 145 (miR-145) during development causes severe cardiopulmonary issues in mice, leading to respiratory distress and early death. This suggests miR-145 has a pathological role beyond smooth muscle development.

Area of Science:

  • Cardiovascular Biology
  • Pulmonary Medicine
  • Developmental Biology

Background:

  • MicroRNA miR-145 is implicated in various cardiopulmonary phenotypes.
  • Studies suggest miR-145 regulates cardiac and vascular smooth muscle cell differentiation.

Purpose of the Study:

  • To investigate the effects of elevated miR-145 in utero on the cardiopulmonary system.
  • To examine the consequences of embryonic, lineage-restricted miR-145 overexpression in mice.

Main Methods:

  • Utilized a transgenic mouse model for embryonic miR-145 overexpression.
  • Examined consequences of enhanced miR-145 expression on survival and cardiopulmonary development.
  • Performed gross analysis and single-cell RNA sequencing on lung tissue.

Main Results:

  • miR-145 overexpression resulted in postnatal lethality by day 18.
  • Overexpressing mice showed respiratory distress, failure to thrive, enlarged right ventricle, and pulmonary dysplasia with vascular hypertrophy.
  • Single-cell sequencing revealed global lung effects, increased immune cells, and vascular inflammation.

Conclusions:

  • Embryonic miR-145 overexpression has detrimental effects on the cardiopulmonary system.
  • These findings demonstrate a pathological role for miR-145 in the cardiopulmonary system.
  • This role extends beyond its known function in smooth muscle differentiation.

Related Concept Videos